Need help? Text us and our team of experts will reply in minutes +00 00 00000

DP3-R

CAS #: 2381089-83-2

DP3-R

Research Use Only

All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.

DP3-R Overview

DP3-R is a synthetic investigational peptide developed as a multi-pathway agonist. It is currently being studied for its potential effects on receptor-mediated signaling, molecular dynamics, and endocrine function in preclinical research models. By activating multiple target receptor subtypes, DP3-R demonstrates broad systemic effects under investigation for their relevance in endocrine and pathway-level research.

Jastreboff A.M. et al. (2023).

History

The development of DP3-R builds on decades of research into peptide signaling science. Early studies with single pathway agonists established their role in downstream signaling and receptor activity. Subsequent research expanded to dual agonist frameworks, paving the way for DP3-R, which uniquely integrates three pathway targets. This multi-agonist design reflects a new direction in peptide research aimed at investigating broader receptor-mediated modulation in preclinical laboratory settings.

Coskun T. et al. (2022).

DP3-R Structure

CAS #: 2381089-83-2

Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈

Molecular Weight: 4845.44 g/mol

PubChem ID: 474492335

Research Findings

DP3-R has been examined in endocrine and systemic models, with studies highlighting its influence on receptor binding kinetics, downstream signaling cascades, lipid pathway dynamics, and integrated endocrine pathways. Research also points to its role in multi-system signaling and pathway characterization in preclinical and laboratory settings.

Key Areas of Research:

  • Endocrine: Receptor binding, signaling, cascades

  • Pathway: Target subtypes, modulation, dynamics

  • Vascular: Lipid pathways, hepatic signaling, markers

  • Systemic: Multi-pathway signaling, resilience, characterization

Together, these findings suggest broad experimental potential for DP3-R across endocrine, vascular, and systemic models. By engaging multiple pathway targets, it provides a versatile research platform for studying downstream signaling cascades and integrated molecular responses across diverse biological systems.

Jastreboff A.M. et al., New England Journal of Medicine, 2023

Our Process

STEP 1

Precision Lyophilization

Manufactured in a controlled U.S. facility under strict compounding standards.

STEP 2

Verified Purity

Every batch third-party tested with HPLC and mass spectrometry.

STEP 3

Same-Day Fulfillment

Orders dispatched same-day from our U.S. facility.
Text us, our dedicated team is here to help
Orders dispatched same-day from our U.S. facility.
Frequently Asked Questions

Orders dispatched same-day from our U.S. facility.

Each vial contains exactly what’s shown on the label. For example, a 10mg vial has exactly 10mg of lyophilized peptide. Researchers can divide it into smaller portions—like four 2.5mg measurements—but the total amount remains 10mg.

Peptides are supplied as lyophilized powder. They do not come reconstituted, and any extra supplies must be sourced separately for research applications.
In lyophilized powder form, peptides stay stable for up to 2 years. After reconstitution, it should be refrigerated and is generally stable for up to 2 months.

Products from Raw Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.

Lyophilized peptides should be stored away from heat and light. Once reconstituted, they must be refrigerated to maintain stability and efficacy.